| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/01/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 38.7k | $10.76 | $416.1k | | 04/01/2023 |
| 04/01/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 6.4k | $0.00 | $0 | | 04/01/2023 |
| 03/20/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 1.2k | $11.12 | $13k | | 01/15/2023 |
| 03/20/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 2.1k | $0.00 | $0 | | 01/15/2023 |
| 03/16/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 543 | $11.46 | $6.2k | | 01/15/2023 |
| 03/16/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 994 | $0.00 | $0 | | 01/15/2023 |
| 01/15/2023 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Class A Common Share | 1.8k | $9.56 | $17.6k | | 01/15/2023 |
| 09/02/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 995 | $0.00 | $0 | | 09/01/2022 |
| 09/02/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 563 | $11.44 | $6.4k | | 09/01/2022 |
| 09/01/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 59.5k | $11.97 | $711.7k | | 09/01/2022 |
| 09/01/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 9.9k | $0.00 | $0 | | 09/01/2022 |
| 07/15/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Class A Common Share | 360 | $9.56 | $3.4k | | 09/01/2022 |
| 04/07/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 59.5k | $11.10 | $660k | | 04/07/2022 |
| 04/07/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Unit | 9.9k | $0.00 | $0 | | 04/07/2022 |
| 03/21/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 1.2k | $10.98 | $13.6k | | 03/21/2022 |
| 03/21/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 2.3k | $0.00 | $0 | | 03/21/2022 |
| 03/16/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Payment of Exercise | Class A Common Share | 544 | $10.13 | $5.5k | | 07/15/2021 |
| 03/16/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Restricted Share Unit | 995 | $0.00 | $0 | | 07/15/2021 |
| 01/15/2022 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Class A Common Share | 1.5k | $9.63 | $14.9k | | 07/15/2021 |
| 09/02/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 8k | $12.97 | $103.2k | | 09/02/2021 |
| 09/02/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 4k | $0.00 | $0 | | 09/02/2021 |
| 07/15/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Class A Common Share | 963 | $11.49 | $11.1k | | 07/15/2021 |